Aptorum Group Ltd Cl A (APM)
$2.63
0.06 (2.23%)
19:15 EST
APM Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
102,200
Day's Range
2.57 - 2.78
52-Week Range
1.16 - 14.23
Dividend & Yield
N/A (N/A)
APM Stock Predictions, Articles, and Aptorum Group Ltd Cl A News
- From InvestorPlace
- From the Web
APM Stock: 9 Things to Know About Aptorum as Shares Fly on Staph Infection Drug News
Aptorum (APM) stock is on the rise Wednesday after announcing approval to move forward with a clinical trial of its staph infection drug.
Is Aptorum Group the Best Buy Among Its Peers?
Aptorum Group has competition in the rapid pathogen identification and detection diagnostics (RPIDD) field. Is APM stock the best bet?
Don’t Get Swept Up In the Unproven Promise of Aptorum Group
Aptorum Group got a boost when the company jumped into the Covid-19 conversation. APM stock looks like a late entry into crowded field.
Why Aptorum’s New Singapore Deal Makes It a Worthwhile Buy
APM stock is a risky name, but the company's recent deal with Singapore has potentially given it a huge opportunity in Asia.
Aptorum Group Is Risky, Despite Popularity
APM stock remains a highly speculative bet for investors as the small biotech company comes with significant risk and volatility.
This Covid-19 Connection Makes Aptorum Group Stock Intriguing
APM stock mostly flew under the radar among biotechnology investors. After a recent price surge, though, the stock is now an attention getter.
APM Stock: Why Aptorum Group Is Soaring 500% Today
APM stock is soaring on news that Aptorum Group is launching a subsidiary focused on liquid biopsies for infectious diseases.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
Sell
